%0 Journal Article %J Experimental Results %D 2021 %T Hepatitis C virus prevalence in Belgium %A L Van Baelen %A Johan Van der Heyden %K Belgium %K cross-sectional study %K Hepatitis C %K population estimate %K Seroprevalence %X

Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. In Belgium, no recent national population-based hepatitis C virus (HCV) seroprevalence estimate is available. The current study estimated HCV prevalence as part of the first Belgian Health Examination Survey, which was organized in 2018 as a second stage of the sixth Belgian Health Interview Survey. This national population-based cross-sectional study resulted in a weighted national HCV seroprevalence of 0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies.

%B Experimental Results %V 2 %8 2021 %G eng